FR2801M - Vaccins dits interférentiels contre les maladies a virus. - Google Patents

Vaccins dits interférentiels contre les maladies a virus.

Info

Publication number
FR2801M
FR2801M FR935354A FR935354A FR2801M FR 2801 M FR2801 M FR 2801M FR 935354 A FR935354 A FR 935354A FR 935354 A FR935354 A FR 935354A FR 2801 M FR2801 M FR 2801M
Authority
FR
France
Prior art keywords
vaccines against
virus diseases
against virus
called interference
interference
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR935354A
Other languages
English (en)
Inventor
Pierre Lepine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PIERRE LEPINE
Original Assignee
PIERRE LEPINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PIERRE LEPINE filed Critical PIERRE LEPINE
Priority to FR935354A priority Critical patent/FR2801M/fr
Priority to BE647466D priority patent/BE647466A/xx
Priority to NL6405530A priority patent/NL6405530A/xx
Priority to GB20888/64A priority patent/GB1059095A/en
Application granted granted Critical
Publication of FR2801M publication Critical patent/FR2801M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR935354A 1963-05-20 1963-05-20 Vaccins dits interférentiels contre les maladies a virus. Expired FR2801M (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR935354A FR2801M (fr) 1963-05-20 1963-05-20 Vaccins dits interférentiels contre les maladies a virus.
BE647466D BE647466A (fr) 1963-05-20 1964-05-04
NL6405530A NL6405530A (fr) 1963-05-20 1964-05-19
GB20888/64A GB1059095A (en) 1963-05-20 1964-05-20 Interferential vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR935354A FR2801M (fr) 1963-05-20 1963-05-20 Vaccins dits interférentiels contre les maladies a virus.

Publications (1)

Publication Number Publication Date
FR2801M true FR2801M (fr) 1964-09-21

Family

ID=8804204

Family Applications (1)

Application Number Title Priority Date Filing Date
FR935354A Expired FR2801M (fr) 1963-05-20 1963-05-20 Vaccins dits interférentiels contre les maladies a virus.

Country Status (4)

Country Link
BE (1) BE647466A (fr)
FR (1) FR2801M (fr)
GB (1) GB1059095A (fr)
NL (1) NL6405530A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309416A (en) * 1979-09-20 1982-01-05 Research Corporation Vaccines from taxonomically similar organisms
BR9307190A (pt) * 1992-10-05 1999-03-30 Sanofi Animal Health Inc Processo de vacinação de um animal contra um agente infeccioso vacina e kit de vacina
DE69426051T2 (de) * 1993-07-30 2001-05-10 Akzo Nobel N.V., Arnheim/Arnhem Impfstoff für Geflügel
ZA978434B (en) * 1996-09-27 1998-03-26 Akzo Nobel Nv Inactivated vaccines.

Also Published As

Publication number Publication date
GB1059095A (en) 1967-02-15
BE647466A (fr) 1964-08-31
NL6405530A (fr) 1964-11-23

Similar Documents

Publication Publication Date Title
FR94491E (fr) Stimulateur cardiaque.
NL141432B (nl) Voor warmte gevoelig kopieervel.
DK111545B (da) Jordbearbejdningsmaskine.
CH440540A (de) Applanations-Tonometer
DK121454B (da) Fremgangsmåde til fremstilling af en hjælpestofholdig vaccine.
FI45966C (fi) Menetelmä kokkiostaattisesti aktiivisten 4-hydroksi-6,7-dialkoksi-3-ka rboalkoksikinoliinien valmistamiseksi.
DK115874B (da) Varmeapparat.
DK123848B (da) Badstueopvarmningsaggregat.
NL142220B (nl) Heetgaszuigermachine.
FI46071C (fi) Menetelmä loistautien hoitoon käytettävän 1-substituoitu-5-nitroimidat soli-2-yylialkyyli-karbamaatin valmistamiseksi.
FR2801M (fr) Vaccins dits interférentiels contre les maladies a virus.
NL151627B (nl) Intra-uterinair contraceptie-orgaan.
FI51175C (fi) Menetelmä terapeuttisesti käytettävien indanyylitiokarbamaattien valmi stamiseksi.
FI45765C (fi) Menetelmä tetanusrokotteen valmistamiseksi.
DK118717B (da) Fremgangsmåde til fremstilling af antidiabetisk virksomme benzensulfonamidopyrimidiner.
DK131816B (da) Stannosaltpræparat.
DK111839B (da) Varmekedel.
DK120649B (da) Skorstenshætte.
CH432776A (de) Zentralheizkessel
AT270013B (de) Regelmäßiger, vieleckiger Körper
NL140969B (nl) Verwarmingsketel.
FI46728C (fi) Menetelmä bronkolyyttisesti vaikuttavien, emäksisesti substitoitujen a lkyyliksantiinijohdannaisten valmistamiseksi.
ES115835Y (es) Colchon climatizado.
DE1923889U (de) Luftheizgeraet.
FR1458982A (fr) Tenaille universelle